News

News Center

Let's strive to achieve a batch of groundbreaking, original breakthroughs in areas like stem cell therapy and regenerative medicine! Beijing has released the "Beijing Plan for Building an International Science and Technology Innovation Center during the 14th Five-Year Period."

2021-11-25

Recently, Beijing released the "Beijing International Science and Technology Innovation Center Construction Plan for the 14th Five-Year Period." The construction plan outlines:

Continuously support the newly established R&D institutions, optimize talent support policies, attract and nurture a high-caliber talent pipeline, encourage independent project selection, and introduce project managers. Strive to achieve a series of groundbreaking, original advancements in areas such as stem cell therapy and regenerative medicine, while proactively planning and establishing a new wave of world-class, cutting-edge R&D institutions in emerging technology fields.

Strengthen the systematic deployment of basic research. Focusing on the strengths of basic research, Deploying in strategic, cutting-edge fields such as stem cells, and actively supporting the implementation of the "Science and Technology Innovation 2030 - Major Projects" and the National Key R&D Program in Beijing.

Support the development of cutting-edge biotechnology research and innovation. Focus on nucleic acid and protein detection, in vivo monitoring of cell function and pathological states, novel in-body intervention techniques targeting specific pathways, next-generation antibody technologies, and gene editing— In cutting-edge core technology areas such as novel cell therapies, stem cells, and regenerative medicine, groundbreaking, internationally leading discoveries are being made—paving the way for precise diagnostics and revolutionary treatment approaches targeting major epidemics, as well as challenging and rare diseases.

Precisely positioning future industries, Focus is placed on cutting-edge technology fields such as genetics and stem cells.

Reprint Notice: This article is reprinted from the official website of the Beijing Municipal People's Government. If any infringement occurs, please contact us for removal.

The "Ethical Assessment Guidelines for Stem Cell Sources," co-drafted by Jiuzhitang Maker, has been officially released.

The "Tianjin Municipal Biopharmaceutical Industry Development Special Plan for the 14th Five-Year Period" has been released, with a focus on building the Bincheng Biopharmaceutical Industry Cluster Core Area.

Here is the title—h1 placeholder text

Online Message

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Business license